ArticleBMC cancer2023

DCLRE1B promotes tumor progression and predicts immunotherapy response through METTL3-mediated m6A modification in pancreatic cancer.

Lincheng Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.